Myung In Pharm Co

Myung In Pharm Co Interest Coverage

The Interest Coverage Ratio of Myung In Pharm Co (317450.KS) as of Nov 18, 2026 is 16.93. In the previous year, Interest Coverage Ratio was 10.56 — a change of 60.28% (higher).

Interest Coverage

16.93

YoY

60.28%

Last updated:

Interest Coverage Ratio of Myung In Pharm Co is 2024 16.93 . Interest Coverage Ratio of Myung In Pharm Co was 2023 10.56 . It decreases by 60.28% higher compared to the previous year.

The Myung In Pharm Co Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2023
10.56 KRW
Jan 1, 2024
16.93 KRW
The Myung In Pharm Co Interest Coverage history
YEARInterest CoverageYoY
16.93+60.28%
10.56—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Myung In Pharm Co Stock analysis

What does Myung In Pharm Co do? Myung In Pharm Co., Ltd. generates revenue through the manufacture and sale of prescription drugs for neurology and psychiatry, including stroke and Parkinson’s disease treatments, schizophrenia, and depression therapies. The company primarily targets domestic and overseas markets, distributing its products under its own brand for neurological and psychiatric conditions. General pharmaceuticals such as dental, oral, digestive system treatments, and other related products form additional revenue streams within its domestic and international sales channels. The firm focuses on prescription drug segments, with key products addressing stroke, Parkinson’s disease, schizophrenia, and depression. These treatments are sold directly to healthcare providers and pharmacies in both domestic and overseas markets. The company also offers general pharmaceuticals like dental and oral treatments, alongside digestive system therapies, contributing to its diversified product portfolio across multiple therapeutic areas. Myung In Pharm’s business model relies on selling branded prescription medications for specific neurological and psychiatric conditions, alongside general pharmaceuticals. Its domestic and overseas market presence ensures consistent revenue from both regional and global healthcare sectors, with no additional details on specific customer segments or pricing strategies disclosed in the provided description. Myung In Pharm Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Myung In Pharm Co stock

Interest Coverage Ratio of Myung In Pharm Co is 16.93 in 2024.

Interest Coverage Ratio of Myung In Pharm Co changed from 10.56 to 16.93, representing a 60.28% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio Myung In Pharm Co since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's Myung In Pharm Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Myung In Pharm Co

All Key Metrics — Myung In Pharm Co